Jump to content

Avadel Pharmaceuticals

From Wikipedia, the free encyclopedia

Avadel Pharmaceuticals plc
Company typePublic
NasdaqAVDL
Industry
  • Healthcare
  • Pharmaceutical
Founded1990; 34 years ago (1990)
Headquarters,
Ireland
Key people
Revenue$ 150.2M (Dec31, 2016)[1]
Websitewww.avadel.com

Avadel Pharmaceuticals plc, is a specialty pharmaceutical company. Avadel markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.[2]

The company was founded as Flamel Technologies SA in Lyon, France in 1990.[3]

The company acquired Éclat Pharmaceuticals of St. Louis, Missouri in March 2012.[4][5]

On 8 February 2016, the company acquired FSC Holdings, LLC, which included its wholly owned subsidiaries FSC Pediatrics, Inc., FSC Therapeutics, LLC, and FSC Laboratories, Inc.[6]

On 3 January 2017, Flamel, Éclat, and FCS Pediatrics became Avadel Pharmaceuticals plc after the Company completed a cross-border merger from France to Ireland.[7]

In 2019, Mike Anderson, CEO of Avadel Pharmaceuticals has resigned, and Gregory Divis, COO of the company was appointed as his temporary successor. Meanwhile, Craig Stapleton, chairman of the Dublin-headquartered Avadel, has also stepped down. That same year, the company filed for Chapter 11 bankruptcy.[8][9]

In May 2023, Avadel Pharmaceuticals received FDA approval for Lumryz, an extended-release oral suspension of sodium oxybate.[10]

References

[edit]
  1. ^ "Company Key Statistics".
  2. ^ "Investor Home". investors.avadel.com. Retrieved 26 June 2017.
  3. ^ "Presentations | Investors | Avadel Pharmaceuticals". investors.avadel.com. Retrieved 17 July 2017.
  4. ^ "About Us". eclatpharma.com. Retrieved 29 December 2014.
  5. ^ "Flamel Technologies Announces Acquisition of Éclat Pharmaceuticals". businesswire.com. 14 March 2012. Retrieved 29 December 2014.
  6. ^ "Flamel Technologies Acquires FSC Pediatrics". marketwired.com. 8 February 2016. Retrieved 7 March 2017.
  7. ^ "Flamel Technologies Completes Cross-Border Merger and Becomes Avadel Pharmaceuticals plc". globenewswire.com (Press release). 3 January 2017. Retrieved 7 March 2017.
  8. ^ "Avadel chief executive resigns suddenly". The Irish Times. 3 January 2019. Archived from the original on 3 January 2019. Retrieved 30 October 2020.
  9. ^ "Avadel Specialty Pharmaceuticals files for Chapter 11 bankruptcy". Wall Street Journal. 7 February 2019. Retrieved 24 February 2023.
  10. ^ Brooks, Megan. "FDA OKs Once-Nightly Sodium Oxybate for Narcolepsy". Medscape. Retrieved 14 July 2023.
[edit]